🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Non-influenza Comparator Vaccine

Found 28 matching trials

A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

PHASE2

"Multimeric-001" (M-001) has been recently developed, containing conserved,...

Status

Completed

Location

Hadassah medical center

Start Date

2011-08

Trial ID

NCT01419925

Treatments Being Tested

Two Multimeric-001 administrations followed by TIV One administration of Multimeric-001 followed by TIV One administration of adjuvanted M-001 followed by TIV One administration of placebo followed by TIV

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

PHASE3

This study will evaluate the safety and immunogenicity in healthy children ...

Status

Completed

Location

Centro de Atención e Investigación Medica - CAIMED

Start Date

2010-09

Trial ID

NCT01209780

Treatments Being Tested

TIV TIVf Comparator TIV

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age

PHASE3

A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...

Status

Completed

Location

MHAT St. Ekaterina

Start Date

2016-09-30

Trial ID

NCT02587221

Treatments Being Tested

MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)Non-Influenza Comparator (Boostrix)

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

PHASE2

This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...

Status

Completed

Location

AMR Tempe

Start Date

2022-08-25

Trial ID

NCT05501561

Treatments Being Tested

Experimental: IIV-A Investigational IIV-A administered as a single dose intramuscularly on Day 1 Experimental: aIIV-B Investigational aIIV-B administered as a single dose intramuscularly on Day 1 Experimental: aIIV-C Investigational aIIV-C administered as a single dose intramuscularly on Day 1 Active Comparator: Licensed IIV IIV administered as a single dose intramuscularly on Day 1

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

PHASE3

Influenza is an acute respiratory disease caused by influenza viruses. Ther...

Status

Completed

Location

Guanyun County Center for Disease Control and Prevention

Start Date

2016-01

Trial ID

NCT02710409

Treatments Being Tested

Quadrivalent influenza vaccine Trivalent influenza vaccine A Trivalent influenza vaccine B

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

PHASE3

This Phase 3/4, randomized, observer-blind, multi-center study, stratified ...

Status

Completed

Location

302 AusTrials Pty Ltd

Start Date

2017-05-25

Trial ID

NCT03165617

Treatments Being Tested

QIVc Non-influenza Comparator Vaccine

A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age

PHASE1

This study will evaluate the safety and immunogenicity of different combina...

Status

Completed

Location

UCL St. Luc - Pharmacy

Start Date

2008-10

Trial ID

NCT00848887

Treatments Being Tested

Adjuvanted and un-adjuvanted influenza vaccines

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

PHASE2

This study will evaluate safety and immunogenicity of a sub-unit Influenza ...

Status

Completed

Location

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio

Start Date

2011-05

Trial ID

NCT01357265

Treatments Being Tested

Seasonal Influenza Vaccine

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

PHASE3

The purpose of this study is to assess the immunogenicity and safety of GSK...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-10-01

Trial ID

NCT02242643

Treatments Being Tested

FluLaval™ Quadrivalent Fluzone® Quadrivalent

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

PHASE3

Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit I...

Status

Completed

Location

222, Novartis Investigational Site

Start Date

2013-11

Trial ID

NCT01964989

Treatments Being Tested

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)

Previous Next